Abstract: Lung cancer is the leading cause of cancer death in China. New approaches of treating lung cancer are urgently needed. With low toxicity and high specificity, immunotherapy is a new treatment. But the implementation is always a challenge because of the immunogenicity and immune escape of lung cancer. In this article we reviewed the current status of development and recent progress in non-specific immune stimulation, cellular immunotherapy, therapeutic cancer vaccines and gene therapy for lung cancer.